Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Postoperative Chylothorax After Open Cardiac Surgery
NCT06833320Phase 2Suspended
- Start
- Sep 2025
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chylothorax comparing Placebo with Propranolol hydrochloride (2 arms). Primary endpoints: Daily heart rates at 24 days, Daily blood pressures at 24 days and 5 more. Started Sep 2025; status: suspended.
02
Drugs
propranolol
03
Conditions
chylothorax
Beyond the preview
Go deeper on NCT06833320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06833320.